☆ 4.6 Editorial Material

The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity

JACC: CARDIOONCOLOGY (2022)

Get Full Text
Add to Collection

Journal

JACC: CARDIOONCOLOGY
Volume 4, Issue 5, Pages 629-634

Publisher

ELSEVIER
DOI: 10.1016/j.jaccao.2022.08.012

Keywords

immunotherapy; mass cytometry; monoclonal antibody; myocarditis; treatment

Categories

Oncology Cardiac & Cardiovascular Systems

Funding

  1. National Institutes of Health [1K08HL16 140501]
  2. Sarnoff Scholar Career Development Award
  3. National Institute of General Medical Sciences [1RM1 GM131981-02]
  4. American Heart Association Established Investi-gator Award
  5. Hoffmann/Schroepfer Foundation
  6. Joan and Sanford I. Weill Scholar Fund
  7. National Heart, Lung, and Blood Institute [R01HL13483004]
  8. American Heart Association [AW849785]
  9. Sanofi
  10. Alnylam
  11. Takeda Pharmaceuticals
  12. Eli Lilly
  13. Amgen
  14. Biotherapeutics
  15. Blueprint Pharmaceuticals
  16. Genentech/Roche
  17. Merck
  18. Nektar Therapeutics
  19. AbbVie
  20. AstraZeneca

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.